Kathryn has more than 20 years’ experience collaborating with clinical researchers from multiple disciplines, including HIV/AIDS clinical trials and cancer clinical research, and providing statistical support for clinical trials and translational studies.

Prior to join Frontier Science, Kathryn was most recently at Dana-Farber Cancer Institute (DFCI), serving as primary statistician for the gynecologic and genitourinary oncology programs of DFCI/Harvard Cancer Center, as well as a senior statistician for the International Breast Cancer Study Group (IBCSG).

Kathryn is the director of Biostatistics at the Frontier Science Foundation (FSTRF). She serves as senior statistician working on the FEND-TB projects. In addition, she oversees a team of statisticians and programmers and provides leadership in International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT)’s collaborations with pharmaceutical companies for licensure studies.

Kathryn received her PhD Degree in Biostatistics from Harvard University.